Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
BMJ Open Sport & Exercise Medicine, 4 (1), e000392
Last month, we shared exciting news about the expansion of provider-based care within our Chronic Condition Management programs
The key difference is that tirzepatide is FDA-approved and commercially available as Mounjaro and Zepbound (~$1,000$1,100/month cash, or $25+ with insurance and savings cards)
In summary, although the application of GLP-1RA in treating tumors is still in the exploratory stage, it has shown significant effects and certain additional health benefits in the treatment of diabetes
J., Alsweiler, J., & Crowther, C
Just the information you need to decide whether this program fits your weight loss journey or drains your budget without meaningful benefit
